Remembering Paul Stuart-Kregor
PMLiVE
by Emily Kimber
3h ago
Those who worked alongside Paul reflect on his dedication to the healthcare industry and his fellow pharma marketers ..read more
Visit website
Merck’s Keytruda regimen granted EC approval for expanded lung cancer use
PMLiVE
by Emily Kimber
3h ago
The approval represents the sixth lung cancer indication for the anti-PD-1 therapy in Europe ..read more
Visit website
Indegene announces acquisition of Trilogy Writing & Consulting
PMLiVE
by Emily Kimber
3h ago
The deal is aimed at increasing Indegene’s clinical and regulatory writing expertise for global market authorisation applications ..read more
Visit website
PMLiVE’s T40 – open for submissions!
PMLiVE
by Emily Kimber
3h ago
Healthcare agencies can submit their entries free of charge with a deadline of 30 April ..read more
Visit website
FDA grants Invivyd’s Pemgarda emergency use authorisation for COVID-19 prevention
PMLiVE
by Jen Brogan
3h ago
The long-acting monoclonal antibody is authorised for use in adults and adolescents ..read more
Visit website
Teva UK and Closed Loop Medicine partner to advance development of personalised medicines
PMLiVE
by Jen Brogan
3h ago
The collaboration will utilise Closed Loop Medicine’s software as a medical device technology platform ..read more
Visit website
Dna Communications appoints Niamh Mangan as executive vice president and managing director
PMLiVE
by Jen Brogan
3h ago
Mangan joins from 90TEN, where she most recently served as managing director ..read more
Visit website
The anthropologists’ advantage
PMLiVE
by Emily Kimber
3h ago
To impress at the strategic review, you first need to understand its hidden meaning ..read more
Visit website
Merck’s Winrevair granted FDA approval to treat pulmonary arterial hypertension in adults
PMLiVE
by Emily Kimber
1d ago
The rare blood vessel disorder affects approximately 500 to 1,000 people in the US every year ..read more
Visit website
AbbVie to expand inflammatory and autoimmune disease portfolio with $212.5m Landos acquisition
PMLiVE
by Jen Brogan
1d ago
The deal will advance the clinical development of NX-13 for patients living with ulcerative colitis and Crohn’s disease ..read more
Visit website

Follow PMLiVE on FeedSpot

Continue with Google
Continue with Apple
OR